Metabolic
Retatrutide
$75.00 CAD
All prices shown in Canadian Dollars (CAD) · 🍁 Ships Canada-wide
A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors. Research shows superior fat loss outcomes, enhanced energy expenditure, improved lipid profiles, and strong metabolic and cardiovascular benefits.
Select size
Specifications
- Purity
- ≥99%
- Quantity
- 10mg
- Storage
- Lyophilized: -20°C. Reconstituted: 2-8°C
- Research Use
- Laboratory research only. Not for human use.
1. Overview
Full name
Retatrutide
Category
Metabolic / Triple Incretin Agonist
Abbreviations
Summary
A next-generation peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. Research highlights some of the most powerful fat loss outcomes recorded for any incretin therapy.
2. What It Does
Primary functions
- Profound reduction in adiposity
- Increased basal energy expenditure
- Enhanced insulin sensitivity
- Powerful appetite suppression
Secondary effects
- Improved lipid metabolism
- Hepatic fat reduction
- Increased lipolysis via glucagon activity
Biological pathways
- GLP-1 receptor signaling
- GIP receptor signaling
- Glucagon receptor (hepatic energy expenditure)
- Hypothalamic satiety circuits
Mechanisms of action
- Triple agonism combines incretin-driven insulin release with glucagon-driven thermogenesis
- Glucagon activation increases hepatic lipid oxidation and resting energy expenditure
- Central appetite suppression via hindbrain and hypothalamic circuits
3. How It Works
Retatrutide engages three metabolic receptors in parallel. GLP-1 and GIP deliver glucose-dependent insulin release and strong appetite suppression, while glucagon agonism raises basal metabolic rate and accelerates hepatic fat oxidation.
This combination produces fat loss exceeding GLP-1 monoagonists and dual agonists in head-to-head research models, while preserving muscle better than aggressive caloric restriction alone.
4. Benefits
Maximal fat loss
Highest weight reduction observed in published incretin research.
Energy expenditure
Glucagon activity raises metabolic rate, not just lowers intake.
Glycemic control
Strong HbA1c and fasting glucose improvements.
Hepatic health
Substantial reduction of liver fat content.
Cardiovascular markers
Improvements in lipids, blood pressure, and inflammation.
Appetite control
Strong suppression of hunger and cravings.
5. Why People Use It
Common goals
- Maximum fat loss
- Metabolic reset
- Body recomposition
Typical use cases
- Severe obesity research
- Metabolic syndrome studies
- NAFLD/NASH research
Popular applications
- Advanced weight loss protocols
- Cardiometabolic optimization
- Energy expenditure studies
Who uses it
- Obesity researchers
- Metabolic scientists
- Body composition specialists
